H.R. 4963 (119th)Bill Overview

Marijuana 1-to-3 Act of 2025

Crime and Law Enforcement|Crime and Law Enforcement
Cosponsors
Support
Lean Republican
Introduced
Aug 12, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for co…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill (Marijuana 1-to-3 Act of 2025) directs the Attorney General to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act. The transfer must be completed by order within 60 days after enactment.

Why people may split

Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.

Watch point

Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe but provides limited accompanying detail.

This bill (Marijuana 1-to-3 Act of 2025) directs the Attorney General to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act.

The transfer must be completed by order within 60 days after enactment.

The text contains no other changes to federal law, regulations, expungement, tax treatment, or state law; it only mandates the rescheduling action.

Passage35/100

On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tractability relative to sweeping reforms. Nevertheless, the subject is politically salient and polarizing enough to produce meaningful opposition and procedural obstacles in the Senate. The absence of compromise features or phased implementation increases the risk that it stalls in committee or on the floor despite its simplicity.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe but provides limited accompanying detail.

Contention60/100

Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies · Employers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesEasier federal research and development: moving marijuana to Schedule III would reduce some administrative barriers to…
  • Federal agenciesReduced federal criminal penalties and enforcement scope: many federal offenses and sentencing enhancements tied to Sch…
  • Potential benefitImproved access to banking and financial services for cannabis businesses: removing the Schedule I classification could…
Likely burdened
  • Federal agenciesDoes not legalize marijuana or resolve state-federal conflicts: critics may note rescheduling leaves marijuana federall…
  • EmployersOngoing regulatory complexity and uncertainty: transitioning schedules would require new DEA/FDA/IRS guidance and could…
  • Federal agenciesPublic health and safety concerns: some critics may argue that lowering federal scheduling could increase availability…
03 · Why people split

Why the argument around this bill splits.

Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as too permissive.
Progressive80%

A mainstream liberal/left-leaning observer would view this bill as a positive, incremental federal step that reduces the legal classification that has been used to block research and justify harsh criminal penalties.

They would appreciate that it acknowledges medical use and lower abuse potential compared with Schedule I.

However, they would also note the bill fails to address key social-justice items (expungement, resentencing, collateral consequences) and other federal impediments to a functioning regulated market.

Leans supportive
Centrist70%

A mainstream centrist/moderate would likely view the bill as an incremental, pragmatic reform: it narrows the federal/drug classification without a sweeping overhaul.

They would appreciate the relatively narrow, administrable change and see potential benefits for research and regulatory clarity, while wanting more analysis of public-safety, fiscal, and administrative consequences.

They would likely support the step but press for legislative follow-up and clear implementation plans.

Leans supportive
Conservative30%

A mainstream conservative/right-leaning observer would likely oppose the bill or view it skeptically, seeing it as federal loosening of drug controls that could increase recreational use and harm public health and safety.

They would emphasize states' rights concerns about a federal signal that normalizes marijuana and worry about youth access, impaired driving, and workplace safety.

Some conservatives might accept modest changes to facilitate research but many would prefer retaining Schedule I or pursuing stricter regulatory/age-limited frameworks tied to states' discretion.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tractability relative to sweeping reforms. Nevertheless, the subject is politically salient and polarizing enough to produce meaningful opposition and procedural obstacles in the Senate. The absence of compromise features or phased implementation increases the risk that it stalls in committee or on the floor despite its simplicity.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • The bill text lacks a cost estimate or analysis of downstream fiscal impacts (e.g., tax revenue, enforcement savings, effects on existing federal programs), which can materially affect committee and floor support.
  • The positions of key administrative actors (Department of Justice, FDA, Treasury) and major stakeholder groups (law enforcement organizations, medical associations, state governments) are unknown and could strongly influence legislative momentum.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Scope of reform: liberals see rescheduling as progress but insufficient without expungement and equity measures; conservatives see it as to…

On content alone the bill is a straightforward administrative change with potentially large downstream effects; that narrowness improves tr…

Unlocked analysis

Relative to its intended legislative type, this bill is a focused, single-action substantive change that clearly directs the Attorney General to reschedule marijuana to Schedule III within a short, specific timeframe bu…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis